Discover 3,600 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,600
New
A Phase 1/2, Single-Dose, Multicenter, Dose Escalation, Clinical Trial to Evaluate the Safety and Efficacy of MR-146: An Open-Label Part 1 in Participants With Stage 1 or 2 Neurotrophic Keratopathy and a Double-Masked Part 2 in Participants With Stage 2 Neurotrophic Keratopathy
for
Neurotrophic Keratopathy
Location: Loma Linda CA, San Diego CA, Sun City AZ, Tucson AZ,
Sponsor: Viatris Inc.
Sex: All
Age: 18+
Code: NCT07923045
Phase 1, Phase 2, Recruiting
Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.
for
Dental Pain and Sensation Disorder, Pain, Postoperative
Location: Loma Linda CA
Sponsor: Loma Linda University
Sex: All
Age: 18 - 59
Code: NCT04860141
Recruiting
Peri-implant Mucosal Changes Over Time Following Implant Provisional Removal in the Esthetic Zone
for
Tooth Loss, Implant Site Reaction
Location: Loma Linda CA
Sponsor: Loma Linda University
Sex: All
Age: 18+
Code: NCT06783595
Recruiting
TB006 for Autism Spectrum Disorder
for
Autism Spectrum Disorder
Location: Phoenix AZ, Aliso Viejo CA
Sponsor: Rossignol Medical Center
Sex: All
Age: 18 - 35
Code: NCT06500637
Phase 2, Recruiting
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
for
Diabetic Foot Infection
Location: Corona CA, Vista CA
Sponsor: MicuRx
Sex: All
Age: 18+
Code: NCT05369052
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
for
Interstitial Cystitis, Bladder Pain Syndrome
Location: Tustin CA, Newport Beach CA, San Diego CA, Las Vegas NV,
Sponsor: Vaneltix Pharma, Inc.
Sex: All
Age: 18+
Code: NCT05737121
Phase 2, Recruiting
Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
for
Alopecia Areata
Location: Fountain Valley CA, Santa Ana CA, San Antonio TX,
Sponsor: ASLAN Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05865041
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
for
Focal Segmental Glomerulosclerosis,
Location: Orange CA, San Francisco CA, Albuquerque NM, El Paso TX,
Sponsor: Sanofi
Sex: All
Age: 16 - 70+
Code: NCT06500702
Phase 2, Recruiting
A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder
for
Major Depressive Disorder
Location: Garden Grove CA, National City CA, Denver CO,
Sponsor: Neuralstem Inc.
Sex: All
Age: 18 - 61
Code: NCT02724735
Recruiting
Maintaining Lower Levels of Care Through Automated Perineal Hygiene
for
Incontinence, Dermatitis
Location: Rancho Palos Verdes CA, Garfield Heights OH
Sponsor: SchwabCare
Sex: All
Age: 18+
Code: NCT03051321
Recruiting
A Controlled Comparison of Pulsed Radiofrequency Vs Physical Therapy on Treating Chronic Knee Osteoarthritis
for
Knee Osteoarthritis
Location: Long Beach CA
Sponsor: VA Long Beach Healthcare System
Sex: All
Age: 18+
Code: NCT02294864
Recruiting
Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)
for
Obesity
Location: Cypress CA
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07225816
Phase 1, Recruiting
Controlled Desaturation Study for Perin Health Patch Validation
for
Oxygen Saturation Measurement
Location: Woodland Hills CA
Sponsor: Perin Health Devices
Sex: All
Age: 18 - 50
Code: NCT06680700
Recruiting
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies